Related references
Note: Only part of the references are listed.FDG-PET/CT in high-risk primary breast cancer-a prospective study of stage migration and clinical impact
Marianne Vogsen et al.
BREAST CANCER RESEARCH AND TREATMENT (2021)
Clinical practice guidelines for high-resolution breast PET, 2019 edition
Yoko Satoh et al.
ANNALS OF NUCLEAR MEDICINE (2021)
Breast Cancer, Version 4.2021 Featured Updates to the NCCN Guidelines
William J. Gradishar et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)
Prospective evaluation of whole-body MRI and 18F-FDG PET/MRI in N and M staging of primary breast cancer patients
Nils Martin Bruckmann et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
Progress and Future Trends in PET/CT and PET/MRI Molecular Imaging Approaches for Breast Cancer
Yue Ming et al.
FRONTIERS IN ONCOLOGY (2020)
The contribution of metabolic parameters of FDG PET/CT prior and during therapy of adult patients with lymphomas
Juan Carlos Prieto Prieto et al.
ANNALS OF NUCLEAR MEDICINE (2020)
PET-CT upstaging of unilateral operable breast cancer and its correlation with molecular subtypes
Srishti Singh et al.
INDIAN JOURNAL OF RADIOLOGY AND IMAGING (2020)
ER+/HER2+ Breast Cancer Has Different Metastatic Patterns and Better Survival Than ER-/HER2+ Breast Cancer
Cletus A. Arciero et al.
CLINICAL BREAST CANCER (2019)
PET/CT radiomics in breast cancer: promising tool for prediction of pathological response to neoadjuvant chemotherapy
Lidija Antunovic et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Breast Cancer Treatment A Review
Adrienne G. Waks et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
PET/CT for Patients With Breast Cancer: Where Is the Clinical Impact?
Gary A. Ulaner
AMERICAN JOURNAL OF ROENTGENOLOGY (2019)
18F-FES PET/CT Influences the Staging and Management of Patients with Newly Diagnosed Estrogen Receptor-Positive Breast Cancer: A Retrospective Comparative Study with 18F-FDG PET/CT
Cheng Liu et al.
ONCOLOGIST (2019)
Predictive Power of a Radiomic Signature Based on 18F-FDG PET/CT Images for EGFR Mutational Status in NSCLC
Xiaofeng Li et al.
FRONTIERS IN ONCOLOGY (2019)
SEOM clinical guidelines in early stage breast cancer (2018)
F. Ayala de la Pena et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2019)
Molecular mechanisms underlying progesterone receptor action in breast cancer: Insights into cell proliferation and stem cell regulation
Mauro E. Cenciarini et al.
STEROIDS (2019)
Factors affecting the accuracy of 18F-FDG PET/CT in evaluating axillary metastases in invasive breast cancer
K. Kutluturk et al.
NIGERIAN JOURNAL OF CLINICAL PRACTICE (2019)
ER and PR expression and survival after endometrial cancer
Deborah Smith et al.
GYNECOLOGIC ONCOLOGY (2018)
Estrogen and progesterone signalling in the normal breast and its implications for cancer development
Heidi N. Hilton et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2018)
Revisiting progesterone receptor (PR) actions in breast cancer: Insights into PR repressive functions
Cecilia J. Proietti et al.
STEROIDS (2018)
18F-FDG-PET/CT scanning-clinical usefulness beyond cancer
S. C. Donnelly
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2018)
Endocrine therapy for ER-positive/HER2-negative metastatic breast cancer
Tomas Reinert et al.
CHINESE CLINICAL ONCOLOGY (2018)
A central role for cadherin signaling in cancer
Antonis Kourtidis et al.
EXPERIMENTAL CELL RESEARCH (2017)
18F-FDG PET/CT in breast cancer: Evidence-based recommendations in initial staging
Ana Paula Caresia Aroztegui et al.
TUMOR BIOLOGY (2017)
Breast cancer subtypes predict the preferential site of distant metastases: a SEER based study
Qi Wu et al.
ONCOTARGET (2017)
Impact of molecular subtypes on metastatic breast cancer patients: a SEER population-based study
Gong Yue et al.
SCIENTIFIC REPORTS (2017)
Classification, Treatment Strategy, and Associated Drug Resistance in Breast Cancer
Yuan Tang et al.
CLINICAL BREAST CANCER (2016)
18F-FDG PET/CT for Staging and Restaging of Breast Cancer
David Groheux et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
E-cadherin-integrin crosstalk in cancer invasion and metastasis
Marta Canel et al.
JOURNAL OF CELL SCIENCE (2013)
Prospective Study of 2-[18F]Fluorodeoxyglucose Positron Emission Tomography in the Assessment of Regional Nodal Spread of Disease in Patients With Breast Cancer: An Ontario Clinical Oncology Group Study
Kathleen I. Pritchard et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Oncologic 18F-FDG PET/CT: Referring Physicians' Point of View
Dimitrios Karantanis et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Association between [18F]fluorodeoxyglucose uptake and prognostic parameters in breast cancer
A. Gil-Rendo et al.
BRITISH JOURNAL OF SURGERY (2009)
Subtypes of breast cancer show preferential site of relapse
Marcel Smid et al.
CANCER RESEARCH (2008)
Share Paper
